Evidence map›Paper›PMID 36054667›Full record

ArticleAmerican journal of hematology2022

The significance of spleen size in children with sickle cell anemia.

Amina Nardo-Marino, Andreas Glenthøj, John N Brewin, Jesper Petersen, Thomas H Braunstein, Jørgen A L Kurtzhals, Thomas N Williams, David C Rees

Open access · hybridAbstract read
In one paragraph

Article in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Amina Nardo-MarinoDanish Centre for Haemoglobinopathies, Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5256-7330
Andreas GlenthøjDanish Centre for Haemoglobinopathies, Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-2082-0738
John N BrewinDepartment of Haematological Medicine, King's College Hospital, London, United Kingdom.ORCID 0000-0002-6129-4300
Jesper PetersenDanish Centre for Haemoglobinopathies, Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-6116-5114
Thomas H BraunsteinCore Facility for Integrated Microscopy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jørgen A L KurtzhalsDepartment of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-2760-8713
Thomas N WilliamsKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID 0000-0003-4456-2382
David C ReesDepartment of Haematological Medicine, King's College Hospital, London, United Kingdom.ORCID 0000-0003-3647-1050
University of Copenhagen · DKCopenhagen University Hospital · DKKing's College London · GBKenya Medical Research Institute · KE

Funding

Wellcome Trust 091758/Z/10/ZWellcome Trust 202800/Z/16/Z
6 · The paper itself

Abstract

It is well established that splenic dysfunction occurs in early childhood in sickle cell anemia (SCA), although the determinants and consequences of splenic injury are not fully understood. In this study, we examined spleen size and splenic function in 100 children with SCA aged 0-16 years at King's College Hospital in London. Spleen size was assessed by abdominal ultrasound (US) and splenic function by pitted red blood cells (PIT counts). In our cohort, 5.6% of children aged 6-10 years and 19.4% of children aged 11-16 years had no visible spleen on US (autosplenectomy). Splenomegaly was common in all age groups, with 28% of children overall having larger spleens than the average for their age. Only one child had a PIT count suggesting preserved splenic function. We found no correlation between hemoglobin F levels and spleen size, nor was there any difference in spleen size between children treated with or without hydroxyurea. Although there was a trend toward increased spleen length in children with co-inherited α-thalassemia, this did not reach statistical significance. Finally, we found a strong association between erythrocyte deformability measured with oxygen gradient ektacytometry, spleen size, and PIT counts. In conclusion, our results do not agree with the general perception that most children with SCA undergo autosplenectomy within the first decade of life and indicate that loss of erythrocyte deformability contributes to loss of splenic filtration capacity in SCA, as well as phenotypical variations in spleen size.

Indexed as

Anemia, Sickle CellSpleenChildChild, PreschoolErythrocyte CountHumansHydroxyureaSplenomegalyHydroxyurea

Identifiers

PMID36054667
PMCPMC9827862
OpenAlexW4293583423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.